Henrik Blou

Henrik Blou is the CEO of Gubra, a world leader in the field of GI, diabetes, obesity, and NASH preclinical research, where Henrik also serves as the Chief Business Officer. Henrik is a Board Member at Dansk Biotek, an industry association of Danish biotechnology companies. With a background in biotechnology and engineering, Henrik has held leadership positions at companies such as Aros Pharma, EpiTherapeutics, and MycoTeQ. Henrik also has experience as a Management Consultant at McKinsey & Company and as a Student Worker at TietoEnator Solutions. Henrik has furthered their education with executive courses at London Business School and holds a master's degree in Engineering from DTU - Technical University of Denmark.